Key Details
Symbol (NSE): SAGCEM
Corporate Action: Amalgamation
Record Date: Not Specified
Nature of Scheme: Amalgamation of Andhra Cements Limited (Transferor Company) with and into Sagar Cements Limited (Transferee Company) under Sections 230 to 232 of the Companies Act, 2013
Entities Involved:
- Transferor Company: Andhra Cements Limited
- Transferee Company: Sagar Cements Limited
Demerged Company: Not Applicable (Amalgamation scheme)
Resulting Company: Sagar Cements Limited (after amalgamation)
Share Entitlement Ratio: Not Specified
Implied Capital Structure Impact: Not Specified
Post-Allotment Listing Plan: Not Specified
Regulatory and Approval Status
NCLT Approval Status: Pending - scheme subject to NCLT approval
Shareholder Approval Status: Pending - requires shareholder approval under Sections 230-232
SEBI/Stock Exchange Observations:
- BSE issued 'no adverse observations' letter dated November 05, 2026
- NSE issued 'no objection' letter dated November 06, 2026
- Both exchanges provided conditional approvals with 21 specific SEBI-mandated disclosure requirements
Effective Date: Not Specified
SEBI Disclosure Requirements
The observation letters incorporate 21 specific conditions from SEBI's letter dated October 30, 2026, including:
1. Disclosure of all ongoing adjudication, recovery proceedings, and enforcement actions against companies, promoters, and directors
2. Requirement for NOC from lending scheduled commercial banks/financial institutions
3. Examination and reporting of complaints
4. Display of additional information submitted after filing on company websites
5. Compliance with all SEBI circulars
6. Transfer of all liabilities from transferor to transferee company
7. Inclusion of abridged prospectus format information for unlisted companies in explanatory statements
8. Use of financials not more than 6 months old in valuation reports
9. Prominent disclosure of scheme details in shareholder notices
10. Comprehensive explanatory statement including:
- Need, rationale, synergies, and cost-benefit analysis of merger
- Details of valuers, merchant bankers, valuation methods, and swap ratio basis
- Pre and post-scheme shareholding patterns
- Capital built-up since incorporation and last 3 years
- Revenue, PAT, and EBITDA for last 3 years
- Asset/liability transfer values and post-merger balance sheet
- Potential benefits and risks analysis
- Financial implications on promoters, public shareholders, and growth prospects
- NCD/NCRPS holder disclosures as per SEBI regulations
11. Disclosure of all pending actions against entities involved
12. Inclusion of all additional information submitted to SEBI
13. Mandatory demat form for equity shares issued under scheme
14. Compliance with all scheme document clauses
15. Prohibition of misstatements or false information
16. No changes to draft scheme without SEBI written consent
17. Incorporation of SEBI/Exchange observations in NCLT petition
18. Compliance with Companies Act 2013 and creditor consent requirements
19. Filing with NCLT only after SEBI/Exchange comments processing
20. Website disclosure of no-objection letters within 24 hours of receipt
21. Clear disclaimer that submission doesn't imply SEBI/Exchange approval
Validity and Conditions
- Observation letters valid for six months from November 06, 2026
- Scheme must be submitted to NCLT within this validity period
- Exchanges reserve right to withdraw approvals if information found incomplete/incorrect/misleading/false
- Companies must file compliance status report for each observation point
- Online filing required through BSE Listing Centre for NCLT notices
Financial Rationale
Not Specified
Impact on Shareholders
Not Specified